CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
RemedyBio is developing a platform to rapidly identify and produce neutralizing antibodies for COVID-19 using its Nanoreactor technology. This approach aims to provide immediate passive immunization for critically ill patients, addressing urgent therapeutic needs during the pandemic.
The SARS-CoV-2 pandemic requires the most serious and rapid healthcare response seen in modern history.
The lag time between the emergence of the pathogen and the implementation of a licensed vaccine still remains an obstacle for prophylactic measures.
In addition, how long immunity lasts for following COVID-19 infection is a big unknown.
The development of immunity to the currently circulating SARS-CoV2 may not provide sterilising protection against subsequent coronavirus infections.
If this we…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
